PE20190566A1 - Aumento de la fertilidad en especies bovinas - Google Patents
Aumento de la fertilidad en especies bovinasInfo
- Publication number
- PE20190566A1 PE20190566A1 PE2019000260A PE2019000260A PE20190566A1 PE 20190566 A1 PE20190566 A1 PE 20190566A1 PE 2019000260 A PE2019000260 A PE 2019000260A PE 2019000260 A PE2019000260 A PE 2019000260A PE 20190566 A1 PE20190566 A1 PE 20190566A1
- Authority
- PE
- Peru
- Prior art keywords
- fertility
- increase
- bovine species
- immunomodulation
- immunogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Dispersion Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a composiciones y metodos de inmunomodulacion que son eficaces para aumentar el porcentaje de concepcion de vacas. La composicion inmunomoduladora comprende un vehiculo de administracion de liposomas cationicos y una molecula de acido nucleico derivada de bacterias aisladas que no codifica para un inmunogeno
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662366772P | 2016-07-26 | 2016-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20190566A1 true PE20190566A1 (es) | 2019-04-22 |
Family
ID=59700165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2019000260A PE20190566A1 (es) | 2016-07-26 | 2017-07-25 | Aumento de la fertilidad en especies bovinas |
Country Status (21)
Country | Link |
---|---|
US (1) | US10933131B2 (es) |
EP (1) | EP3490598A1 (es) |
JP (1) | JP2019525935A (es) |
KR (1) | KR102473370B1 (es) |
CN (1) | CN109689095B (es) |
AR (1) | AR109167A1 (es) |
AU (1) | AU2017301528A1 (es) |
BR (1) | BR112019001599A2 (es) |
CA (1) | CA3031778A1 (es) |
CL (1) | CL2019000185A1 (es) |
CO (1) | CO2019000724A2 (es) |
CR (1) | CR20190037A (es) |
DO (1) | DOP2019000018A (es) |
IL (1) | IL264380A (es) |
MX (1) | MX2019001126A (es) |
NZ (1) | NZ750181A (es) |
PE (1) | PE20190566A1 (es) |
SG (1) | SG11201900710YA (es) |
TW (1) | TWI759317B (es) |
UY (1) | UY37346A (es) |
WO (1) | WO2018022583A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102514899B1 (ko) * | 2022-03-04 | 2023-03-29 | 경북대학교 산학협력단 | 암소 번식 능력 개선용 조성물 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
US4812314A (en) * | 1986-02-24 | 1989-03-14 | Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization | Lipid replacement therapy |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
EE200200158A (et) * | 1999-09-25 | 2003-06-16 | University Of Iowa Research Foundation | Immunostimulatoorsed nukleiinhapped |
EP1551221A4 (en) * | 2002-07-03 | 2007-08-01 | Coley Pharm Group Inc | NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES |
AU2002953015A0 (en) | 2002-12-02 | 2002-12-12 | Women's And Children's Hospital | Modified lacz gene |
AU2005271247A1 (en) | 2004-08-13 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Antibiotic resistance free DNA vaccines |
EP2429581B1 (en) | 2009-05-14 | 2015-08-05 | Bayer Intellectual Property GmbH | Enhanced immune response in avian species |
RU2606855C2 (ru) | 2010-12-22 | 2017-01-10 | Байер Интеллектчуал Проперти Гмбх | Повышение иммунного отклика у видов крупного рогатого скота |
CA2820499A1 (en) * | 2013-06-18 | 2014-12-18 | Bayer Intellectual Property Gmbh | Enhanced immune response in bovine species |
RU2530520C1 (ru) * | 2013-08-02 | 2014-10-10 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечернозёмной зоны Российской Федерации Российской академии сельскохозяйственных наук | Средство для оптимизации воспроизводительной функции коров |
KR20160122849A (ko) * | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
CN108472255A (zh) | 2015-06-26 | 2018-08-31 | 拜耳动物保健有限责任公司 | 调节胞质dna监测分子的方法 |
JP2018521109A (ja) | 2015-07-31 | 2018-08-02 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Animal Health Gmbh | ぶた種における免疫応答の増強 |
CA2994039A1 (en) | 2015-07-31 | 2017-02-09 | Bayer Animal Health Gmbh | Enhanced immune response in aquatic species |
-
2017
- 2017-07-25 TW TW106124943A patent/TWI759317B/zh active
- 2017-07-25 CR CR20190037A patent/CR20190037A/es unknown
- 2017-07-25 CA CA3031778A patent/CA3031778A1/en active Pending
- 2017-07-25 AU AU2017301528A patent/AU2017301528A1/en active Pending
- 2017-07-25 US US16/320,256 patent/US10933131B2/en active Active
- 2017-07-25 PE PE2019000260A patent/PE20190566A1/es unknown
- 2017-07-25 SG SG11201900710YA patent/SG11201900710YA/en unknown
- 2017-07-25 NZ NZ750181A patent/NZ750181A/en unknown
- 2017-07-25 JP JP2019504080A patent/JP2019525935A/ja active Pending
- 2017-07-25 BR BR112019001599A patent/BR112019001599A2/pt unknown
- 2017-07-25 WO PCT/US2017/043662 patent/WO2018022583A1/en unknown
- 2017-07-25 EP EP17757587.5A patent/EP3490598A1/en not_active Withdrawn
- 2017-07-25 CN CN201780056532.9A patent/CN109689095B/zh active Active
- 2017-07-25 MX MX2019001126A patent/MX2019001126A/es unknown
- 2017-07-25 KR KR1020197004661A patent/KR102473370B1/ko active IP Right Grant
- 2017-07-26 AR ARP170102110A patent/AR109167A1/es unknown
- 2017-07-26 UY UY0001037346A patent/UY37346A/es not_active Application Discontinuation
-
2019
- 2019-01-21 IL IL264380A patent/IL264380A/en unknown
- 2019-01-24 DO DO2019000018A patent/DOP2019000018A/es unknown
- 2019-01-24 CL CL2019000185A patent/CL2019000185A1/es unknown
- 2019-01-25 CO CONC2019/0000724A patent/CO2019000724A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2019525935A (ja) | 2019-09-12 |
CN109689095A (zh) | 2019-04-26 |
DOP2019000018A (es) | 2019-07-31 |
SG11201900710YA (en) | 2019-02-27 |
TW201817427A (zh) | 2018-05-16 |
WO2018022583A1 (en) | 2018-02-01 |
CL2019000185A1 (es) | 2019-06-28 |
IL264380A (en) | 2019-02-28 |
CN109689095B (zh) | 2023-10-03 |
EP3490598A1 (en) | 2019-06-05 |
NZ750181A (en) | 2023-02-24 |
KR102473370B1 (ko) | 2022-12-05 |
TWI759317B (zh) | 2022-04-01 |
US10933131B2 (en) | 2021-03-02 |
KR20190032434A (ko) | 2019-03-27 |
UY37346A (es) | 2018-02-28 |
US20190388538A1 (en) | 2019-12-26 |
AU2017301528A1 (en) | 2019-02-14 |
CO2019000724A2 (es) | 2019-02-08 |
BR112019001599A2 (pt) | 2019-10-01 |
CR20190037A (es) | 2019-05-16 |
MX2019001126A (es) | 2019-08-14 |
AR109167A1 (es) | 2018-11-07 |
CA3031778A1 (en) | 2018-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20180266A1 (es) | Composiciones que comprenden cepas bacterianas | |
PE20180243A1 (es) | Composiciones que comprenden cepas bacterianas | |
BR102014027466A8 (pt) | Sequência recombinante, uso de uma planta, uma parte de planta, ou uma célula de planta de soja, método para preparação de uma célula de planta transgênica, e loci genômicos de soja não gênicos purificados | |
BR112018007622A2 (pt) | ferramenta genética de transformação de bactérias clostridium | |
BR112017025004A2 (pt) | composições compreendendo cepas bacterianas | |
BR102014027438A8 (pt) | Sequência recombinante, uso de uma planta, de uma parte de planta, ou de uma célula de planta de milho, método para preparação de uma célula vegetal transgênica, e sequências recombinante e genômica de milho | |
BR102014027442A8 (pt) | Sequência recombinante, uso de uma planta, uma parte de planta, ou uma célula de planta de maís, método de preparação de uma célula vegetal transgênica e loci genômicos de maís não gênico purificados | |
CO2017008455A2 (es) | Anticuerpos contra tau | |
BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
AR096869A1 (es) | Neurotoxinas catiónicas | |
CL2018001546A1 (es) | Formulaciones líquidas que contienen fungicidas | |
CY1117209T1 (el) | Συνθεσεις περιλαμβανοντας 15-ηερε και μεθοδοι χρησης των ιδιων | |
BR112017009988A2 (pt) | xampus e condicionadores com efeito condicionador | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
ECSP18024466A (es) | Composiciones de micropartículas que comprenden saflufenacil | |
BR112018012304A2 (pt) | composições e métodos para diminuir expressão de tau | |
MX2020001885A (es) | Formulaciones de daptomicina. | |
CL2018002769A1 (es) | Composiciones y métodos recombinantes de inmunoglobulina intravenosa (rlvig) para producción y uso. | |
ECSP19008417A (es) | Anticuerpos con inmunogenicidad baja y usos de estos | |
MX2017016896A (es) | Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos. | |
MX2021007914A (es) | Composiciones curables que comprenden poliolefinas insaturadas. | |
PE20180659A1 (es) | Peptidos lipidados resistentes a proteasas | |
PE20190566A1 (es) | Aumento de la fertilidad en especies bovinas | |
CO2017001320A2 (es) | Composición de lhrh inmunogénica | |
BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença |